Adverse Reaction to Drug Recruiting Phase Trials for Ulinastatin (DB12038)

IndicationStatusPhase
DBCOND0042486 (Adverse Reaction to Drug)RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02520570Post-market Safety Reassessment of Ulinastatin for Injection